Hu, Dawei <br/><br/>
A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China.  [electronic resource] 

 -  Rheumatology international  Jan 2009 
 - 297-303 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0172-8172 
<br/><br/><label>Standard No.: </label>10.1007/s00296-008-0681-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Antirheumatic Agents--administration & dosage<br/>Arthritis, Rheumatoid--drug therapy<br/>China<br/>Double-Blind Method<br/>Etanercept<br/>Female<br/>Humans<br/>Immunoglobulin G--administration & dosage<br/>Injections, Subcutaneous<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Receptors, Tumor Necrosis Factor--administration & dosage<br/>Recombinant Fusion Proteins--administration & dosage<br/>Treatment Outcome<br/>Young Adult